This compound increases expression of genes associated with lipid metabolism such as SIRT1, FOXO1 and PPARγ and could therefore be considered for the treatment of obesity and metabolic impairment. The gene discussed is FOXO1; the disease is obesity due to melanocortin 4 receptor deficiency.